Home Tingsn Medical's 7th ICE Product, TINGSN Sonic Eyes 8 Pro, Receives NMPA Approval — Further Expanding China’s Indigenous Intracardiac Echocardiography Portfolio

Tingsn Medical's 7th ICE Product, TINGSN Sonic Eyes 8 Pro, Receives NMPA Approval — Further Expanding China’s Indigenous Intracardiac Echocardiography Portfolio

Jun 25, 2026 15:19 CST Updated 15:19
TINGSN

Developer of Cardiac Interventional Treatment Devices

Image

Good News

TINGSN's 7th ICE Product

TINGSN Sonic Eyes 8 Pro Approved!

Image
Image
Image

June 23, 2026,TINGSN Sonic Eyes 8 Pro Disposable Intracardiac Echocardiography Diagnostic CatheterOfficially approved by the National Medical Products Administration (NMPA), successfully obtaining the Class III Medical Device Registration Certificate.

This approval marksTINGSN Secures Its 7th NMPA Medical Device Registration Certificate, also our clinical-facing launch5. Independently Developed ICE Intracardiac Echocardiography Catheter. The launch of the new product marks another upgrade to our portfolio of domestically produced ICE products, further filling the gap in high-end, small-diameter ICE devices in China and continuously solidifying our leading position as a domestic pioneer in the field of intracardiac echocardiography.

Deeply Cultivating Independent Innovation, Delivering Hardcore Products to Clinical Practice: TINGSN Is Always on the Way.



01

Slender 8F Catheter Diameter, Broader Clinical Adaptability, Benefiting More Patients



The newly approved TINGSN Sonic Eyes 8 Pro, equipped with8F Precision Effective Diameter, achieving a perfect balance between slim catheter diameter and stable performance under the positioning of high-performance flagship products.

Compared with traditional large-bore catheters, the 8F slim outer diameter significantly improves vascular traversability, effectively reduces the puncture wound size, and markedly lowers surgical risks such as intraoperative vascular injury and bleeding. The product not only fully adapts to conventional adult atrial fibrillation ablation and interventional procedures for structural heart disease, but also specifically addressesElderly patients with slender vessels and poor vascular conditionsclinical surgical challenges, greatly expanding the clinical application boundaries of ICE technology, allowing precise and safe green electrophysiology technology to benefit more patients.

Image



02

New Ergonomic Handle, Optimizing the Operator's Experience to the Fullest




Addressing the pain points of clinical practice, TINGSN Sonic Eyes 8 Pro has undergone a comprehensive upgrade in human-computer interaction, adoptingBrand-New Ergonomic Exclusive Handle Design

The handle conforms to the ergonomic contour of the physician’s grip, ensuring stable holding and comfortable feel, effectively alleviating hand fatigue and soreness caused by prolonged, high-intensity surgeries. Meanwhile, the product is equipped with high-precision four-way deflection technology, offering responsive steering and smooth control damping. It enables large-angle exploration across the entire cardiac chamber, making key procedures such as atrial septal puncture, left atrial appendage assessment, and valve examination more precise and efficient. The design closely aligns with the clinical operational habits of cardiologists, comprehensively enhancing surgical practical experience and efficiency.



03

All-in-One Disposable Design: Safe and Controllable, Cost-Effective and Efficient for Primary Care Empowerment



Building on the core advantages of TINGSN’s ICE series, the TINGSN Sonic Eyes 8 Pro adheres to a single-use sterile design, fundamentally eliminating the risk of cross-infection associated with device reuse. It strictly avoids instrument wear and safety hazards caused by repeated sterilization and use, fully meeting hospitals’ stringent requirements for infection prevention and control.

Leveraging a complete, 100% independently developed and domestically mass-produced supply chain, the new product effectively reduces clinical procurement and application costs while matching the core performance of imported high-end 8F ICE products. By breaking down the price barriers associated with imported devices, it facilitates the adoption of advanced intracardiac echocardiography (ICE) technology across hospitals at all levels and accelerates the widespread implementation of green electrophysiology procedures characterized by zero or low radiation exposure.


04

Matrix Optimization: Fortifying the Core Barriers of Domestic ICE Autonomy



From the launch of the first domestically developed ICE catheter to the current comprehensive market release of five ICE catheter models holding seven registration certificates, TINGSN has successfully established a full-spectrum ICE product portfolio, covering the 8F economy series, the 8F flagship Pro series, and the 10F series.

A comprehensive, multi-tiered product portfolio precisely meets the needs of routine electrophysiology procedures in primary care hospitals and complex, high-difficulty structural heart disease interventions in tertiary A hospitals, while satisfying both domestic clinical applications and overseas market expansion. The recent approval of Sonic Eyes 8 Pro addresses the gap in China’s high-end 8F flagship intracardiac echocardiography (ICE) products, enabling direct competition with imported premium devices and further accelerating the import substitution process for cardiovascular interventional imaging equipment.

Meanwhile, leveraging its mature 2D ICE technology platform, the company continues to deepen its R&D in cutting-edge 4D ICE technologies. Clinical exploration and technological iteration are advancing steadily, continuously building and strengthening its technical barriers and innovation advantages in the field of domestic intracardiac echocardiography.



05

Empowering Clinical Practice Across All Scenarios to Safeguard Cardiac Interventional Procedures




Sonic Eyes 8 Pro is widely compatible with mainstream interventional procedures in cardiology, providing comprehensive support throughout clinical surgeries:

✅ Atrial fibrillation ablation procedures including radiofrequency, PFA, and cryoablation

✅ Real-time monitoring during transseptal puncture and left atrial appendage closure

✅ Real-time Monitoring During PFO/ASD Closure Procedure

The product provides real-time, high-definition visualization of intracardiac anatomical structures, device positioning, and hemodynamic changes during procedures, precisely guiding surgical operations and providing early warnings for intraoperative complications such as pericardial effusion. It significantly reduces intraoperative X-ray radiation exposure, creating a safer, greener, and more efficient interventional surgery solution for both patients and operators.



Conclusion

Driven by Innovation, Crafted with Care for Heart Health.

As a domestic innovator deeply rooted in the field of intracardiac echocardiography (ICE), TINGSN remains committed to addressing clinical needs and pursuing independent research and development, continuously iterating its core products and refining its product portfolio. Looking ahead, we will continue to focus on the cardiovascular interventional imaging sector, break through technical bottlenecks, and support the high-quality development of domestic cardiovascular diagnosis and treatment technologies with higher-quality, more accessible Chinese-made medical devices, contributing TINGSN’s strength to advancing the localization and innovation of healthcare in China.

Follow TINGSN to unlock more innovative achievements in domestic intracardiac echocardiography!

  END   


Image